SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

DRREDDYS LABORATORIES

BSE: 500124 20 May 2025
Healthcare
₹ 1223
Dr. Reddy's Laboratories Ltd., specializes in Pharmaceuticals within the Healthcare sector.

DRREDDYS LABORATORIES - Share Price & Details

Market Cap
₹1,03,285
High /Low
1,421 / 1,020
Stock P/E
18.2
Book Value
₹402.0
Dividend Yield
0.65
ROCE
23.1
ROE
₹18.3
Face Value
1.0
PEG Ratio
0.8
EVEBITDA
₹10.9
Debt
4,677
CMP / FCF
42.8
Debt to equity
₹0.14
NP Ann
5,725
High price all time
1,421
Piotroski score
₹2.0
Graham Number
783.0
No. Eq. Shares
83.4
Net CF
₹726
Net profit
5,725
Price to book value
3.07
Interest Coverage
₹28.2
Low price all time
60.5
Industry PE
30.8
Reserves
₹33,466
Free Cash Flow
₹1,327

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic0.700.190.61NA4.1732.1
Triochem Products Ltd.,4.590.88NA3.600
DR.REDDYS LABORATORIES LTD.59773.012007.055629.014.391,03,28518.2
APOLLO HOSPITALS ENTERPRISE LT21,627.003,416.0020,548.0023.7610096677.1
LUPIN LTD.45344.612913.544856.728.219436028.8

Peer Comparison Chart


About DRREDDYS LABORATORIES

Dr. Reddy's Laboratories Ltd.,, with Security Code 500124, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Buzzing stocks: Dr Reddy’s Lab, BEL, Lumax Auto, KSB, RPP Infra, LNG-related companies, KEC International, Brigade, Sapphire Media, Newton Software

(19 May 2025)
Dr Reddy's Laboratories has said that the United States Food & Drug Administration (USFDA) has completed a GMP inspection at its API...
Read more →

Stocks to watch today: Delhivery, BEL, Vodafone Idea, Sun Pharma, Divi’s Lab, Bajaj Auto, NBCC, Dr Reddy’s in focus ahead of Q4 results

(19 May 2025)
Stocks to watch today include Delhivery, Bharat Electronics (BEL), Vodafone Idea, Sun Pharma, Divi's Lab, Bajaj Auto, NBCC, and Dr Reddy's...
Read more →

Dr Reddy's receives two USFDA observations for New York API facility

(17 May 2025)
India Business News: Dr. Reddy's Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483 with two observations...
Read more →

Dr Reddys Gets Two Observations From US FDA For New York API Plant

(17 May 2025)
Dr. Reddy's Laboratories Ltd. on Saturday said the US health regulator has issued a Form 483 with two observations after inspecting its...
Read more →

Dr Reddy's Labs New York facility gets 2 USFDA observations

(17 May 2025)
Hyderabad: Dr Reddy's Labs has announced that the United States Food & Drug Administration (USFDA) has issued two observations for the...
Read more →

Dr Reddy’s receives two USFDA observations for API facility in New York

(17 May 2025)
Dr Reddy's Laboratories receives Form 483 with two observations from US health regulator after facility inspection.
Read more →